Business Context and Reporting Period
The Clorox Company (CLOROX CO) filed a Form 8-K Current Report on September 26, 2017, regarding a corporate financing event. The report details the execution of an underwriting agreement for a public debt offering, which subsequently closed on September 28, 2017.
Key Financial Metrics
This filing reports on a specific capital raising transaction rather than operational performance metrics such as revenue, profit, or cash flow.
- Debt Issuance: $400 million aggregate principal amount.
- Instrument: 3.100% Senior Notes due 2027.
- Transaction Type: Underwritten registered public offering.
- Trustee: Wells Fargo Bank, National Association.
The filing text does not provide a clear value for the company's current liquidity, existing debt levels, or operating margins.
Material Changes
The primary material change is the increase in the company's long-term debt obligations by $400 million following the closing of the offering. This represents a new liability with a maturity date of 2027 and a fixed interest rate of 3.100%.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future business outlook, revenue guidance, or specific risk factors related to operations. The document focuses strictly on the legal execution of the debt offering and the attachment of the Underwriting Agreement, Supplemental Indenture, and legal opinion.
Investor Verification Checklist
- Verify the use of proceeds from the $400 million note issuance in subsequent filings or press releases.
- Confirm the impact of the new 3.100% interest obligation on the company's overall debt service coverage.
- Review the Sixth Supplemental Indenture (Exhibit 4.1) for specific covenants or restrictions associated with the new notes.
- Check for any changes in the company's credit rating following this issuance.